Knowledge Tree
Levodopa
Also known as: L-dopa
Facts (11)
Sources
Extent and Health Consequences of Chronic Sleep Loss and ... - NCBI ncbi.nlm.nih.gov 9 facts
referenceBergonzi et al. (1975) studied sleep organization in patients with Parkinson’s syndrome before and after treatment with L-dopa combined with a dopa-decarboxylase inhibitor.
claimLevodopa (L-dopa), a dopamine precursor, is a medication used to treat Restless Legs Syndrome.
claimLevodopa (L-dopa), a dopamine precursor, is a medication used to treat Restless Legs Syndrome (RLS) that significantly reduces symptoms and periodic limb movements occurring throughout the night, as reported by Brodeur et al. (1988).
referenceLeeman AL, O'Neill CJ, Nicholson PW, Deshmukh AA, Denham MJ, Royston JP, Dobbs RJ, and Dobbs SM studied the response to and optimal spacing of nighttime levodopa dosing for Parkinson’s disease in the elderly in a 1987 study published in the British Journal of Clinical Pharmacology.
claimLeeman AL et al. studied the response to and optimal spacing of night time dosing with levodopa for Parkinson’s disease in the elderly in 1987.
referenceBrodeur C, Montplaisir J, Godbout R, and Marinier R published a study titled 'Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: A double-blind, controlled study' in Neurology in 1988 (Volume 38, Issue 12, pages 1845–1848).
claimAdministration of levodopa (L-dopa) significantly reduces symptoms of Restless Legs Syndrome and periodic limb movements that occur throughout the night, though it is associated with some adverse effects.
claimMedications used to treat Parkinson’s disease, specifically dopamine precursors like levodopa/carbidopa and dopamine agonists like pramipexole and ropinirole, can promote sleep when used in low doses, but high doses may cause increased nocturnal wakefulness, decreased slow-wave sleep (SWS), and decreased sleep continuity (Leeman et al., 1987; Monti et al., 1988; Cantor and Stern, 2002).
referenceKales A et al. studied sleep in patients with Parkinson’s disease and normal subjects before and after levodopa administration, published in Clinical Pharmacology and Therapeutics in 1971.
Overview of Anxiety Disorders - Psychiatry - MSD Manuals msdmanuals.com 1 fact
claimMedications used to treat medical disorders can induce anxiety, including albuterol, corticosteroids, and theophylline for asthma; amphetamines and other stimulants for attention deficit/hyperactivity disorder; levothyroxine and liothyronine for hyperthyroidism; antihistamines and decongestants for seasonal allergies; phenytoin for seizure disorders; and levodopa for Parkinson disease.
Bridging the Gap Between LLMs and Evolving Medical Knowledge arxiv.org Jun 29, 2025 1 fact
measurementThe relationship between Levodopa and Parkinson’s disease in the Medical Knowledge Graph (MKG) received a reliability rating of 9.6/10 from LLM analysis and 10/10 from medical expert analysis, and it increases query accuracy by 24% regarding Parkinson’s treatments and comorbidities.